ImmuCell Corporation (NASDAQ:ICCC) Q4 2025 Earnings Call Transcript March 5, 2026
Operator: Good morning, and welcome to the ImmuCell Corporation Conference Call to discuss Unaudited Fourth Quarter and Full Year 2025 Financial Results. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference call over to Joe Diaz of Lytham Partners. Please go ahead.
Joe Diaz: Thank you, Bailey, and good morning to all. As the conference call operator...
